Senator Investment Group LP Sage Therapeutics, Inc. Transaction History

Senator Investment Group LP

  • $2.03 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 13, 2019
SELL
$140.29 - $189.96 $21 Million - $28.5 Million
-150,000 Closed
0 $0
Q2 2019

Aug 14, 2019
SELL
$157.85 - $183.09 $11.8 Million - $13.7 Million
-75,000 Reduced 33.33%
150,000 $27.5 Million
Q1 2019

May 15, 2019
BUY
$89.33 - $163.65 $20.1 Million - $36.8 Million
225,000 New
225,000 $35.8 Million

Others Institutions Holding SAGE

# of Institutions
198
Shares Held
46.5M
Call Options Held
402K
Put Options Held
209K
View Full List

About Sage Therapeutics, Inc.

SAGE Quotes by TradingView
  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $326M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Senator Investment Group LP Portfolio

Follow Senator Investment Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Senator Investment Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Senator Investment Group LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email